GSK Completes Global Media Review, Awards Media Business to Omnicom's PHD and Mediacom

by Shirley Johanna on  September 15, 2015 at 6:01 PM Medico Legal News
RSS Email Print This Page Comment bookmark
Font : A-A+

Pharma and consumer-health giant GlaxoSmithKline has awarded its Ģ1.1 billion global media agency account and planning business to incumbent agencies PHD and MediaCom.
GSK Completes Global Media Review, Awards Media Business to Omnicom's PHD and Mediacom
GSK Completes Global Media Review, Awards Media Business to Omnicom's PHD and Mediacom

The global account includes Novartis vaccine business, which GSK bought from its rival pharma company in March as part of a wider deal for $5.25 billion.

MediaCom is expected to retain the European element of the global media account, while PHD will retain the US business. The final discussions are still underway. The account is estimated to be worth $1.7 billion (Ģ1.1 billion).

Novartis selected Publicis Groupe's Startcom MediaVest won $600 million global media account in December 2011 but withdrew from this summer's consolidated review.

The Novartis media account is believed to not include Sandoz, the generic pharmaceuticals division of Novartis.

GSK consolidated the bulk of its global media buying and planning account two years ago with WPP media agency network GroupM and Omnicom's PHD.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive